The Joint Committee on Diabetes Nephropathy and The Working Group for Updated Staging of Diabetic Nephropathy 2023
-
- Babazono Tetsuya
- The Japanese Diabetes Society The Joint Committee on Diabetes Nephropathy The Working Group for Updated Staging of Diabetic Nephropathy 2023 Division of Diabetology and Metabolism, Department of Internal Medicine, Tokyo Womenʼs Medical University School of Medicine
-
- Kanasaki Keizo
- The Japanese Diabetes Society The Joint Committee on Diabetes Nephropathy The Working Group for Updated Staging of Diabetic Nephropathy 2023 Department of Internal Medicine, Faculty of Medicine, Shimane University
-
- Utsunomiya Kazunori
- The Japanese Diabetes Society The Joint Committee on Diabetes Nephropathy Nomura Hospital
-
- Koya Daisuke
- The Japanese Diabetes Society The Joint Committee on Diabetes Nephropathy Omi Medical Center
-
- Watada Hirotaka
- The Japanese Diabetes Society The Joint Committee on Diabetes Nephropathy Juntendo University Department of Medicine, Metabolism & Endocrinology
-
- Emoto Masanori
- The Japanese Diabetes Society The Joint Committee on Diabetes Nephropathy Metabolism, Endocrinology, and Molecular Medicine, Nephrology, Osaka Metropolitan University Graduate School of Medicine
-
- Kawanami Daiji
- The Japanese Diabetes Society The Joint Committee on Diabetes Nephropathy Department of Endocrinology and Diabetes Mellitus, Fukuoka University School of Medicine
-
- Fukami Kei
- The Joint Committee on Diabetes Nephropathy The Working Group for Updated Staging of Diabetic Nephropathy 2023 Japanese Society of Nephrology Division of Nephrology, Department of Medicine, Kurume University School of Medicine
-
- Kume Shinji
- The Working Group for Updated Staging of Diabetic Nephropathy 2023 Japanese Society of Nephrology Department of Medicine, Shiga University of Medical Science
-
- Suzuki Yoshiki
- The Joint Committee on Diabetes Nephropathy Japanese Society of Nephrology JR East Niigata Health Promotion Center
-
- Wada Jun
- The Joint Committee on Diabetes Nephropathy Japanese Society of Nephrology Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
-
- Wada Takashi
- The Joint Committee on Diabetes Nephropathy Japanese Society of Nephrology Kanazawa University
-
- Okada Hirokazu
- The Joint Committee on Diabetes Nephropathy Japanese Society of Nephrology Department of Nephrology, Saitama Medical University
-
- Narita Ichiei
- The Joint Committee on Diabetes Nephropathy Japanese Society of Nephrology Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences
-
- Koiwa Fumihiko
- The Joint Committee on Diabetes Nephropathy The Working Group for Updated Staging of Diabetic Nephropathy 2023 The Japanese Society for Dialysis Therapy Division of Nephrology, Department of Internal Medicine, Showa University Fujigaoka Hospital
-
- Abe Masanori
- The Joint Committee on Diabetes Nephropathy The Working Group for Updated Staging of Diabetic Nephropathy 2023 The Japanese Society for Dialysis Therapy Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon University School of Medicine
-
- Tsuchiya Ken
- The Joint Committee on Diabetes Nephropathy The Japanese Society for Dialysis Therapy Department Blood Purification, Kidney Center, Tokyo Womenʼs Medical University
-
- Kato Akihiko
- The Joint Committee on Diabetes Nephropathy The Japanese Society for Dialysis Therapy Blood Purification Unit, Hamamatsu University Hospital
-
- Ichikawa Kazuko
- The Joint Committee on Diabetes Nephropathy Japan Society of Metabolism and Clinical Nutrition Nutrition Department, Osafune Clinic
-
- Kitatani Naomi
- The Joint Committee on Diabetes Nephropathy Japan Society of Metabolism and Clinical Nutrition Center for Metabolism and Clinical Nutrition, Kansai Electric Power Hospital
Bibliographic Information
- Other Title
-
- 糖尿病性腎症病期分類2023の策定
- トウニョウビョウセイジンショウビョウキ ブンルイ 2023 ノ サクテイ
Search this article
Abstract
<p>In Japan, the Classification (or Staging) of Diabetic Nephropathy revised in 2014 has been widely used. Since 2022, the Joint Committee on Diabetic Nephropathy has discussed the need to revisit the staging due to the diverse kidney phenotype in individuals with diabetes against the background of aging of the population, an increase in obese individuals, and the development of new therapeutic agents for diabetes and hypertension. As of now, no new evidence has been presented that suggest the necessity of changing the basic framework of the 2014 staging, which was based on the levels of albuminuria and estimated glomerular filtration rate. Therefore, the Committee has decided not to alter the fundamental structure of the 2014 staging. However, with a focus on maintaining consistency with the CKD classification by the Japanese Society for Nephrology and international notation, the former stages have been renamed as follows:"normal albuminuria (stage 1)", "microalbuminuria (stage 2)", "macroalbuminuria (stage 3)", "severely decreased GFR/end-stage kidney disease (stage 4)", and "kidney replacement therapy (stage 5)".</p>
Journal
-
- Nihon Toseki Igakkai Zasshi
-
Nihon Toseki Igakkai Zasshi 56 (11), 393-400, 2023
The Japanese Society for Dialysis Therapy
- Tweet
Details 詳細情報について
-
- CRID
- 1390016880929685760
-
- NII Book ID
- AN10432053
-
- ISSN
- 1883082X
- 13403451
-
- NDL BIB ID
- 033213491
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL
- Crossref
-
- Abstract License Flag
- Disallowed